Abstract Background Individuals with subjective memory complaints (SMC) feature a higher risk of cognitive decline and clinical progression of Alzheimer’s disease (AD). However, the pathological mechanism underlying SMC remains unclear. We aimed to assess the intrinsic connectivity network and its relationship with AD-related pathologies in SMC individuals. Methods We included 44 SMC individuals and 40 normal controls who underwent both resting-state functional MRI and positron emission tomography (PET). Based on graph theory approaches, we detected local and global functional connectivity across the whole brain by using degree centrality (DC) and eigenvector centrality (EC) respectively. Additionally, we analyzed amyloid deposition and tau...
Objective: Amnesia in Alzheimer's disease (AD) appears early and could be caused by encoding deficie...
A prominent finding of postmortem and molecular imaging studies on Alzheimer's disease (AD) is the a...
The abnormality occurs at molecular, cellular as well as network levels in patients with Alzheimer’s...
Amyloid-β pathology (Aβ) and impaired cognition characterize Alzheimer's disease (AD); however, neur...
Background: Amyloid-β accumulation was found to alter precuneus-based functional connectivity (FC) i...
BACKGROUND Amyloid-β accumulation was found to alter precuneus-based functional connectivity (FC)...
IntroductionChanges in intrinsic functional connectivity (iFC) have been reported at various stages ...
Background. We aimed to investigate how altered intrinsic connectivity networks (ICNs) affect pathol...
The abnormality occurs at molecular, cellular as well as network levels in patients with Alzheimer&#...
Cortical accumulation of amyloid beta is one of the first events of Alzheimer's disease pathophysiol...
Beta-amyloid (Aβ) deposition is one of the hallmarks of Alzheimer's disease (AD). However, it is als...
There is striking overlap between the spatial distribution of amyloid-β pathology in patients with A...
In Alzheimer's disease (AD), amyloid-β (Aβ) pathology and intrinsic functional connectivity (iFC) in...
Research indicates that a subtle cognitive decline, accompanied by pathological changes, occurs in i...
Neuropsychiatric syndromes are highly prevalent in Alzheimer's disease (AD), but their neurobiology ...
Objective: Amnesia in Alzheimer's disease (AD) appears early and could be caused by encoding deficie...
A prominent finding of postmortem and molecular imaging studies on Alzheimer's disease (AD) is the a...
The abnormality occurs at molecular, cellular as well as network levels in patients with Alzheimer’s...
Amyloid-β pathology (Aβ) and impaired cognition characterize Alzheimer's disease (AD); however, neur...
Background: Amyloid-β accumulation was found to alter precuneus-based functional connectivity (FC) i...
BACKGROUND Amyloid-β accumulation was found to alter precuneus-based functional connectivity (FC)...
IntroductionChanges in intrinsic functional connectivity (iFC) have been reported at various stages ...
Background. We aimed to investigate how altered intrinsic connectivity networks (ICNs) affect pathol...
The abnormality occurs at molecular, cellular as well as network levels in patients with Alzheimer&#...
Cortical accumulation of amyloid beta is one of the first events of Alzheimer's disease pathophysiol...
Beta-amyloid (Aβ) deposition is one of the hallmarks of Alzheimer's disease (AD). However, it is als...
There is striking overlap between the spatial distribution of amyloid-β pathology in patients with A...
In Alzheimer's disease (AD), amyloid-β (Aβ) pathology and intrinsic functional connectivity (iFC) in...
Research indicates that a subtle cognitive decline, accompanied by pathological changes, occurs in i...
Neuropsychiatric syndromes are highly prevalent in Alzheimer's disease (AD), but their neurobiology ...
Objective: Amnesia in Alzheimer's disease (AD) appears early and could be caused by encoding deficie...
A prominent finding of postmortem and molecular imaging studies on Alzheimer's disease (AD) is the a...
The abnormality occurs at molecular, cellular as well as network levels in patients with Alzheimer’s...